Home > Quotes > LIFE > Guru Analysis > Kenneth Fisher
 
 
 
 Save Stocks
This stock is currently not trading. Visit our ATYR PHARMA INC IPO page, for the latest information regarding the IPO.

  for the Price/Sales Investor based on the criteria of Kenneth Fisher. Return to LIFE Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch %
Benjamin Graham %
Validea %
Motley Fool %
David Dreman %
Martin Zweig %
Kenneth Fisher %
James P. O'Shaughnessy %



Detailed Analysis

Guru Score: %


PRICE/SALES RATIO: [FAIL]

The prospective company should have a low Price/Sales ratio. However, LIFE's P/S is not available which means an opinion cannot be rendered at the present time on this variable. This is the most important variable according to this methodology, and therefore the remainder of the analysis will be provided for informational purposes.


TOTAL DEBT/EQUITY RATIO: [FAIL]

Less debt equals less risk according to this methodology. The Debt/Equity ratio for LIFE is not available currently. Hence, this variable cannot be analyzed at the present time.


PRICE/RESEARCH RATIO: [PASS]

This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. LIFE is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.


PRELIMINARY GRADE: No Interest in LIFE At this Point

Is LIFE a "Super Stock"? NO




LONG-TERM EPS GROWTH RATE: [FAIL]

This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. LIFE's inflation adjusted EPS growth rate is not available. Hence, this methodology cannot analyze this criterion at the present time.


FREE CASH PER SHARE: [FAIL]

This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. LIFE's free cash per share is not available. Hence, this methodology cannot analyze this variable currently.


THREE YEAR AVERAGE NET PROFIT MARGIN: [FAIL]

This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. LIFE's three year net profit margin average is not available. Hence an opinion cannot be rendered on this criterion at the present.

 
The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer
The Validea Market Legends ETF (VALX)